Skip to main content

Table 5 Costs among ICU patients (n = 15,014) with and without new-onset atrial fibrillation (NOAF)

From: New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults—a multicenter retrospective cohort study

Characteristic

New-onset atrial fibrillation (n = 1541)

No atrial fibrillation (n = 13,473)

P value

Total costs, $, mean (SD)

50,799 (38,473)

41,832 (38,772)

< 0.001

Total direct costs, $, mean (SD)

37,392 (31,538)

30,231 (32,922)

< 0.01

Total cost per survivor, $

81,120

59,710

 

Attributable costs, $, mean (SD)

 Food services

1046 (1104)

937 (1032)

0.37

 Health professionals (non-physician or nursing)

2859 (2175)

2957 (2.250)

0.45

 Laboratory

2144 (1910)

1877 (1823)

< 0.01

 Medical imaging

1438 (1672)

1401 (1573)

0.29

 Pharmacy

3582 (3288)

2893 (3092)

< 0.001

 Respiratory therapy

3944 (6188)

3748 (6229)

0.48

 Nursing

39,492 (36,493)

28,344 (31,302)

< 0.001

ICU costs, $, mean (SD)

 Total costs

41,303 (37,743)

28,298 (41,393)

< 0.001

 Direct costs

31,874 (30,838)

21,323 (21,504)

< 0.001

 Indirect costs

9239 (8482)

7367 (8043)

0.08

  1. Abbreviations: IQR interquartile range, NEMS Nine Equivalents of Nursing Manpower Scale, SD standard deviation